 |
 |

Correlation of Regional Proton Magnetic Resonance Spectroscopic Metabolic Changes With Cognitive Deficits in Mild Alzheimer Disease
Sophie Chantal, MPs;
Martin Labelle, MSc;
Rémi W. Bouchard, MD, MSc, FRCPC;
Claude M. J. Braun, PhD;
Yvan Boulanger, PhD
Arch Neurol. 2002;59:955-962.
Context The staging of Alzheimer disease (AD) dementia could be improved by
a neurometabolic analysis using magnetic resonance spectroscopy.
Objective To examine the correlation between regional cerebral metabolic alterations
measured by proton magnetic resonance spectroscopy and neuropsychological
dysfunctions in patients with early AD.
Design A case-control study.
Setting University hospital neurology clinic and radiology department.
Participants A cohort of 14 patients with mild AD and 14 control subjects paired
for age and sex.
Interventions Single-voxel proton magnetic resonance spectroscopic brain examination
(60 minutes) and a comprehensive battery of psychometric tests (2 hours).
Main Outcome Measures Metabolite ratios relative to unsuppressed water were calculated for
magnetic resonance spectroscopic metabolites (N-acetylaspartate,
choline, creatine-phosphocreatine, and myo-inositol)
in the medial temporal lobes (MTLs), parietotemporal cortices (PTCs), and
frontal cortices of both hemispheres. Correlations were examined between metabolic
changes in an area and psychometric scores of its known regional function:
MTL and verbal memory, PTC and language and visuoconstructional abilities,
and frontal cortices and executive functions.
Results A significant reduction of N-acetylaspartate/water
(H2O) in the left MTL and of choline/H2O in both MTLs,
as well as a significant increase of myo-inositol/H2O in the right PTC were observed. Metabolic alterations in the left
MTL were correlated with a loss of verbal memory, in the left PTC with language
impairment, and in the right PTC with a loss of visuoconstructional abilities
in the group with AD.
Conclusion These findings are consistent with regional distribution of neuropathologic
changes and cognitive symptoms characterizing early phases of AD, and with
the pattern of lateralization of normal brain function.
From Clinique de la Mémoire/Recherche-Alzheimer, Hôpital
de l'Enfant-Jésus du Centre Hospitalier Affilié Universitaire
de Québec, Université Laval, Quebec City (Ms Chantal and Dr
Bouchard); Centre de Neurosciences Cognitives, Université du Québec
à Montréal, Montreal (Ms Chantal and Dr Braun); and Département
de Radiologie, Hôpital Saint-Luc du Centre Hospitalier de l'Université
de Montréal, Montreal (Mr Labelle and Dr Boulanger), Quebec.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(6):1048-1050.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
MR Spectroscopy, Functional MRI, and Diffusion-Tensor Imaging in the Aging Brain: A Conceptual Review
Minati et al.
J Geriatr Psychiatry Neurol 2007;20:3-21.
ABSTRACT
Neuropsychological predictors of dependency in patients with Alzheimer disease
Sarazin et al.
Neurology 2005;64:1027-1031.
ABSTRACT
| FULL TEXT
Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients
Chao et al.
Neurology 2005;64:282-289.
ABSTRACT
| FULL TEXT
|